Patents Assigned to Altana Pharma, AG
  • Tetrahydropyridoethers
    Patent number: 7393860
    Abstract: The compound (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h] [1,7] naphthyridine inhibits the secretion of gastric acid.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: July 1, 2008
    Assignee: Altana Pharma AG
    Inventor: Jörg Senn-Bilfinger
  • Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors
    Patent number: 7390819
    Abstract: The compounds of formula I in which R1, R2, R3 and A have the meanings as given in the description are novel effective INOS inhibitors.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: June 24, 2008
    Assignee: Altana Pharma AG
    Inventors: Thomas Martin, Wolf-Ruediger Ulrich
  • Indolopyridines,Benzofuranopyridines and Benzothienopyridines
    Publication number: 20080125452
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R4, R5 and X have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.
    Type: Application
    Filed: January 26, 2006
    Publication date: May 29, 2008
    Applicant: ALTANA PHARMA AG
    Inventors: Matthias Vennemann, Thomas Bar, Jurgen Braunger, Petra Gimmnich, Thomas Beckers, Mathias Schmidt, Thomas Ciossek, Sandra Nappe
  • Imidazopyridine-Derivatives As Inducible No-Synthase Inhibitors
    Publication number: 20080125460
    Abstract: The compounds of Formula (I) in which R1, R2, Het1 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 30, 2004
    Publication date: May 29, 2008
    Applicant: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Novel 6-Pyridylphenanthridines
    Publication number: 20080119505
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Har have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: January 31, 2006
    Publication date: May 22, 2008
    Applicant: ALTANA Pharma AG
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Johannes Barsig, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley
  • Substituted Imidazo [4,5-B] Pyridines As Inhibitors Of Gastric Acid Secretion
    Publication number: 20080119510
    Abstract: The invention provides compounds of the formula (I) in which the substituents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Application
    Filed: December 6, 2005
    Publication date: May 22, 2008
    Applicant: Altana Pharma AG
    Inventors: Christof Brehm, Wilm Buhr, M. Vittoria Chiesa, Andreas Palmer, Peter Jan Zimmermann, Wolfgang-Alexander Simon, Stefan Postius, Wolfgang Kromer
  • Cyclic benzimidazoles
    Publication number: 20080113963
    Abstract: The invention is directed to processes for preparing cyclic benzimidazoles, which compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Application
    Filed: November 1, 2007
    Publication date: May 15, 2008
    Applicant: ALTANA PHARMA AG
    Inventors: M. Chiesa, Peter Zimmermann, Wilm Buhr
  • Difluoro-Substituted Imidazopyridines
    Publication number: 20080114020
    Abstract: The invention provides compounds of the formula (I) in which the substituents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Application
    Filed: October 13, 2005
    Publication date: May 15, 2008
    Applicant: Altana Pharma AG
    Inventors: Wilm Buhr, Peter Jan Zimmermann, Christof Brehm, Adreas Palmer, M.Vittoria Chiesa, Wolfgang-Alexander Simon, Stefan Postius, Wolfgang Kromer, Georg Rast, Udo Doelling
  • Tetrahydropyridothiophenes for the Treatment of Proliferative Diseases Such as Cancer
    Publication number: 20080096914
    Abstract: Compounds of a certain formula (I), in which Ra and Rb have the meanings indicated in the description, are novel effective compounds with anti-proliferative and apoptosis inducing activity.
    Type: Application
    Filed: February 8, 2006
    Publication date: April 24, 2008
    Applicant: ALTANA Pharma AG
    Inventors: Klaus Pekari, Mathias Schmidt, Thomas Bar, Thomas Beckers, Bjorn Bartels
  • Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic Excipient
    Publication number: 20080050428
    Abstract: The invention relates to novel extended release dosage forms for reversible proton pump antagonists comprising a basic excipient.
    Type: Application
    Filed: September 30, 2005
    Publication date: February 28, 2008
    Applicant: Altana Pharma AG
    Inventors: Hartmut Ney, Isabel Anstett-Klein, Simone Hiltl, Antje Brueck-Scheffler
  • Pharmaceutical Composition Comprising Roflumilast or the N-Oxide of Roflumilast
    Publication number: 20080045572
    Abstract: An aqueous pharmaceutical preparation for administration of a slightly soluble PDE4 inhibitor is described.
    Type: Application
    Filed: September 21, 2005
    Publication date: February 21, 2008
    Applicant: Altana Pharma AG
    Inventor: Rudolf Linder
  • Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
    Patent number: 7329677
    Abstract: The compounds of formula (I) in which R1, R2, R3, R4 and R11 have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: February 12, 2008
    Assignee: Altana Pharma AG
    Inventor: Thomas Fuchss
  • Device and Method for Monitoring the Functioning of the Lower Esophageal Sphincter
    Publication number: 20080033274
    Abstract: The present invention relates to a device for monitoring the functioning of the lower esophageal sphincter in mammals.
    Type: Application
    Filed: May 23, 2005
    Publication date: February 7, 2008
    Applicant: Altana Pharma AG
    Inventor: Stefan Postius
  • 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
    Publication number: 20080033006
    Abstract: The invention provides compounds of the formula 1, in which the substituents and symbols are defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Application
    Filed: January 25, 2005
    Publication date: February 7, 2008
    Applicant: Altana Pharma AG
    Inventor: Wilm Buhr
  • Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
    Patent number: 7326784
    Abstract: The invention relates to compounds of the formula 1, in which R1, R2, R3, Arom and PG have the meanings as indicated in the description. These compounds are valuable intermediates for the preparation of pharmaceutically active compounds.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: February 5, 2008
    Assignee: Altana Pharma AG
    Inventors: Andreas Palmer, Ulrike Nettekoven
  • 8-Substituted imidazopyridines
    Patent number: 7326718
    Abstract: The present invention relates to 8-substituted imidazopyridines of a certain formula (1) in which the substitutents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Grant
    Filed: November 15, 2003
    Date of Patent: February 5, 2008
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger, Peter Jan Zimmermann
  • Aminopyridine-derivatives as inductible no-synthase inhibitors
    Patent number: 7317021
    Abstract: The compounds of Formula (I) in which R1, R2, R3 and R4 have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: January 8, 2008
    Assignee: Altana Pharma AG
    Inventor: Thomas Fuchss
  • Tricyclic n-acyl compounds
    Patent number: 7314935
    Abstract: The invention relates to compounds of the formula (1) where the substituents and symbols are as defined in the description. The compounds are valuable intermediates for preparing active pharmaceutical ingredients.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: January 1, 2008
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger, Peter Jan Zimmerman, Peter Zimmerman
  • 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines
    Publication number: 20070287726
    Abstract: The invention relates to compounds of the formula (1) wherein the substituents and symbols have the meanings indicated in the description. The compounds have gastric acid secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Application
    Filed: July 29, 2005
    Publication date: December 13, 2007
    Applicant: Altana Pharma AG
    Inventor: Andreas Palmer
  • Cyclic benzimidazoles
    Patent number: 7307084
    Abstract: The invention relates to cyclic benzimidazoles of formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: December 11, 2007
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, M. Vittoria Chiesa, Peter Jan Zimmermann